The 17-1A antigen is expressed on primar
β
Bernward Passlick; Wulf Sienel; Rita Seen-Hibler; Werner WΓΆckel; Olaf Thetter; K
π
Article
π
2000
π
John Wiley and Sons
π
French
β 294 KB
π 1 views
In view of the high incidence of early distant tumor relapses in apparently completely resected (R0, M0) non-small cell lung cancer (NSCLC), there is a need for an adjuvant therapy. Considering the low tumor burden in these patients, an adjuvant therapy with monoclonal antibodies (i.e., the 17-1A MA